Bruker Corp.

  • Taking a Look at Agilent Technologies

    By Ryan Palmer - July 11, 2013 | Tickers: AFFX, A, BRKR

    Agilent Technologies (NYSE: A) calls itself the world's premier measurement company. Providing bio-analytical and electronic measurement solutions to various industries, Agilent operates in four reportable segments.

    These segments all provide tools that aid companies in analyzing the physical and biological properties of substances and products. The segments are distinguished more by customer base than services provided. 

    Aglient's four segments

    Life sciences - Provides tools and services which enable customers more »

  • A Board Member Is Bullish About This Industrial Equipment Stock

    By Meena Krishnamsetty - March 14, 2013 | Tickers: BIO, BRKR, FEIC, PLL, ST

    According to a Form 4 filed with the SEC, Pall Corporation (NYSE: PLL) Board member Craig Owens directly purchased close to 3,000 shares of the company’s stock on March 4th at an average price of about $67.82 per share. He now owns almost 5,000 shares of the stock, meaning that this purchase more than doubled his stake in the company. Pall is a $7.6 more »

  • What Are Insiders Buying Recently?

    By Meena Krishnamsetty - December 13, 2012 | Tickers: BRKR, CLSN, DF, EXEL

    Our database of insider trading filings allows us to pick out companies that have seen recent insider purchases- studies show that on average stocks bought by insiders tend to beat the market- and take a brief look at the company to see if it might be worth investigating further. It’s impossible to buy every stock that insiders are buying, but it’s certainly possible to use insider buying as more »

  • This Cyclical Stock Disappoints With its Outlook

    By Lee Samaha - November 21, 2012 | Tickers: A, BRKR, CSCO, INTC, TER

    I think that Agilent (NYSE: A) is a great barometer of a cyclical companies willingness to undergo capital expenditures. If companies are expanding CapEx then they will need to invest in test and measurement instrumentation. With this in mind Agilent’s recent results and commentary were not exactly encouraging. I want to break them down and see the areas of relative strengths/weaknesses with reference to Agilent’s and other more »

  • This Week's Key Earnings Reports

    By Lee Samaha - November 3, 2012 | Tickers: BRKR, CHD, COV, JWN, WFM

    Earnings season starts to wind down this week, but that doesn’t mean that there aren’t some fascinating results to look forward to. The main bellwethers have already reported, so this week it is all about filling in the gaps in your view of the economy and looking for individual stock ideas. As usual I’m going to highlight a few that I think are interesting and suggest some more »

  • Which Stocks are Insiders Buying this Week?

    By Meena Krishnamsetty - September 24, 2012 | Tickers: AGCO, BBG, BRKR, NS, RAM

    Studies show that insider purchases tend to be bullish signs for a stock.  Because these purchases can be important signals for how a stock is going to do, we track insider buys so that investors can review these stocks further and see if any particular one might be a good investment for them as well. Here are five stocks that insiders have been buying recently. 

    The CEO of Bruker (NASDAQ: BRKRmore »)

  • This Company’s CEO Bought Over $1 Million in Stock

    By Meena Krishnamsetty - September 19, 2012 | Tickers: A, BRKR, DHR, FEIC, TMO

    Frank Laukien, CEO and President of Bruker Corporation (NASDAQ: BRKR) has disclosed to the SEC that he directly purchased 100,000 shares on September 14th at an average price of $13 per share. At Insider Monkey, we like to track insider activity because it can give an indication of what people with more information than us about the company think about its future prospects. In particular, insider purchases tend more »

  • What This Company's Results Mean for Your Stock

    By Lee Samaha - September 19, 2012 | Tickers: A, BRKR, INTC, XXIA, TMO

    It’s always useful to get an industry read across from a company that services many different end markets. In this article I will focus on Agilent Technologies Inc (NYSE: A). It is a cyclical stock and has suffered over the summer as global growth has turned out weaker than expected. However within its end markets there are some varied trends of which investors can either avoid or take advantage more »

  • Huge Insider Ownership? – Count Me In!

    By Chad Henage - April 10, 2012 | Tickers: BRKR, CLR, TMO

    When the top people in a company own a huge chunk of shares, it's usually a positive sign. When a top officer in the company owns shares, their interests align more with the common shareholder. They care more about how to increase the value of the company and thus the stock, and they are less concerned about just making money from their salary.

  • J.P. Morgan Healthcare Conference Schedule: Day One

    By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

    The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

    I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)